Literature DB >> 30101705

MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.

Long Zhao1, Xiaoping Tang1, Renguo Luo1, Jie Duan1, Yuanchuan Wang1, Binbin Yang1.   

Abstract

BACKGROUND: Glioma is a type of tumor that starts in the glial cells of brain and spine. However, the underlying molecular mechanisms of miRNAs dysregulation in glioma initiation and progression is largely unclear.
OBJECTIVE: To further understand the molecular mechanism of miR-490-5P functions and how miR-490 regulated CCND1 function.
METHODS: The expression of miR-490-5P in glioma tissues and cells was measured by qRT-PCR and ISH. Cell transfection is responsible for miR-490-5P overexpression and knockdown. CCK-8 and clone formation assay are applicable to examine the capacity of glioma cells proliferation. Cell cycle analysis is used to test glioma cells cycle distribution with miR-490-5P overexpression or downregulation. Further, in vivo tumor exnograft studies are used to examine the effects of miR- 490-5P on glioma malignancy in vivo.
RESULTS: We found overexpression of miR-490 lead to glioma cells cycle arrest at G1 phase and decreased proliferation. Next-step functional assays showed miR-490 regulated CCND1 expression and manipulated giloma cells proliferation. Finally, negative regulation of miR-490 in CCND1 function was validated through in vivo nude mice tumorigenesis assay and IHC examination in glioma tissue.
CONCLUSION: Overall, these results showed that epigenetic regulation of CCND1 via miR-490 was essential to glioma and provide a new insight into glioma diagnosis, treatment, prognosis and further translational investigations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CCND1; Epigenetic modificaiton; G1 phase arrest; Glioma; MiR-490; glioma cells.

Mesh:

Substances:

Year:  2018        PMID: 30101705     DOI: 10.2174/1567202615666180813130143

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  6 in total

1.  miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.

Authors:  Jingjie Wang; Meixin Zhang; Xinhui Hu; Jiajun She; Ruonan Sun; Shanshan Qin; Dandan Li
Journal:  FEBS Open Bio       Date:  2021-03-23       Impact factor: 2.792

2.  Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma.

Authors:  Min Yuan; Lili Yao; Guzhalinuer Abulizi
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

3.  MicroRNA-497-5p Induces Cell Cycle Arrest Of Cervical Cancer Cells In S Phase By Targeting CBX4.

Authors:  Yani Chen; Juan Du; Yu Wang; Haiyan Shi; Qiuyu Jiang; Yangfeng Wang; Huahua Zhang; Yameng Wei; Wanjuan Xue; Zhiying Pu; Yi Gao; Dan Li; Yun Feng; Jing Yan; Jing Zhang
Journal:  Onco Targets Ther       Date:  2019-12-02       Impact factor: 4.147

4.  Long non-coding RNA CCAT1 sponges miR-490 to enhance cell proliferation and migration of non-small cell lung cancer.

Authors:  Jingluan Wang; Nina Sun; Weizhong Han; Li Tong; Tao Xu; Guo Li
Journal:  Thorac Cancer       Date:  2020-12-15       Impact factor: 3.500

5.  Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database.

Authors:  Li-Li Quan; Jin-Yang Liu; Li-Xia Qu; Hui La; Hai-Li Wang; Xiao-Xia Chen; Na Wang; Zhen-Zhi Wei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.